tiprankstipranks
Trending News
More News >
Advertisement

GEND - AI Analysis

Compare

Top Page

GEND

Genter Capital Dividend Income ETF (GEND)

Rating:70Outperform
Price Target:
$12.50
The Genter Capital Dividend Income ETF (GEND) demonstrates solid performance, supported by strong holdings like Cisco (CSCO) and BlackRock (BLK). Cisco contributes positively with its strategic focus on AI infrastructure and innovation, while BlackRock adds stability through robust financial performance and earnings sentiment. However, weaker holdings such as Altria Group (MO), with financial risks from high leverage and declining cigarette volumes, slightly weigh on the fund's overall rating. The ETF's diversified portfolio helps mitigate risks, though concentration in certain sectors may require monitoring.
Positive Factors
Strong Top Holdings
Several key holdings, such as JPMorgan Chase and CVS Health, have delivered strong year-to-date performance, supporting the fund's overall returns.
Sector Diversification
The ETF is spread across ten sectors, including Health Care, Financials, and Energy, reducing reliance on any single industry.
Reasonable Expense Ratio
With an expense ratio of 0.38%, the fund offers relatively low costs compared to actively managed ETFs.
Negative Factors
High U.S. Concentration
The ETF has over 96% exposure to U.S. companies, limiting diversification across global markets.
Underperforming Holdings
Some holdings, like M&T Bank, have shown weak year-to-date performance, potentially dragging on overall returns.
Small Asset Base
With assets under management of just over $2.8 million, the fund may face liquidity challenges compared to larger ETFs.

GEND vs. SPDR S&P 500 ETF (SPY)

GEND Summary

The Genter Capital Dividend Income ETF (GEND) is designed for investors who want steady income through dividends. It focuses on companies with a strong history of paying high dividends across various industries, such as healthcare, financials, and energy. Some well-known companies in this ETF include Altria Group and Cisco Systems. This ETF is a good choice for those looking to diversify their portfolio while earning consistent income. However, new investors should be aware that its performance can fluctuate with the market, and it relies heavily on dividend-paying companies, which may face challenges during economic downturns.
How much will it cost me?The Genter Capital Dividend Income ETF (GEND) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting dividend-rich stocks rather than tracking a passive index. The higher cost reflects the additional research and management involved in curating its portfolio.
What would affect this ETF?The Genter Capital Dividend Income ETF (GEND) could benefit from stable economic conditions and low interest rates, which often support dividend-paying stocks, particularly in sectors like Health Care and Financials that make up a significant portion of its portfolio. However, rising interest rates or economic uncertainty could negatively impact dividend-focused investments, as companies may face challenges maintaining payouts. Additionally, sector-specific risks, such as regulatory changes in Health Care or volatility in Energy prices, could influence the ETF's performance.

GEND Top 10 Holdings

The Genter Capital Dividend Income ETF (GEND) leans heavily into U.S.-based dividend powerhouses, with a notable focus on health care, financials, and energy. CVS Health is a standout, rising steadily thanks to strong earnings momentum and a positive outlook, while Cisco Systems adds stability with its strategic innovation in AI. On the flip side, M&T Bank and AT&T are dragging the fund, with bearish technical trends and lingering challenges in revenue growth and debt management. Overall, GEND’s sector diversification provides balance, but its reliance on a few lagging names tempers performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Cisco Systems4.34%$122.22K$287.08B30.42%
79
Outperform
JPMorgan Chase4.26%$120.01K$839.66B36.99%
70
Outperform
Altria Group4.17%$117.57K$106.30B26.69%
68
Neutral
Enbridge4.15%$116.92K$102.72B16.56%
70
Outperform
CVS Health4.11%$115.74K$104.26B46.13%
77
Outperform
Northern4.09%$115.12K$24.35B24.45%
66
Neutral
BlackRock3.63%$102.37K$183.58B14.42%
78
Outperform
M&T Bank3.59%$101.23K$27.88B-7.31%
74
Outperform
Chevron3.46%$97.56K$315.56B3.78%
73
Outperform
Emerson Electric Company3.38%$95.24K$75.71B23.51%
73
Outperform

GEND Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
11.25
Positive
100DMA
10.99
Positive
200DMA
Market Momentum
MACD
0.02
Negative
RSI
52.21
Neutral
STOCH
88.56
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GEND, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 11.28, equal to the 50-day MA of 11.25, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 52.21 is Neutral, neither overbought nor oversold. The STOCH value of 88.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GEND.

GEND Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.83M0.38%
70
Outperform
$482.64M0.50%
73
Outperform
$172.42M0.59%
70
Outperform
$70.61M0.35%
70
Outperform
$29.17M0.45%
67
Neutral
$8.90M0.34%
74
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GEND
Genter Capital Dividend Income ETF
11.29
1.34
13.47%
FDV
Federated Hermes U.S. Strategic Dividend ETF
TBG
TBG Dividend Focus ETF
FDIV
MarketDesk Focused U.S. Dividend ETF
DIVY
Sound Equity Income ETF
JHDV
John Hancock U.S. High Dividend ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement